Trial Outcomes & Findings for Clinical Performance of Two Daily Disposable Soft Contact Lenses (NCT NCT05138783)
NCT ID: NCT05138783
Last Updated: 2023-04-18
Results Overview
Visual Acuity (VA) was collected for each eye individually with study lenses in place using a letter chart. VA was measured in logarithm of the minimum angle of resolution (logMAR). A logMAR value of 0 corresponds to 20/20 Snellen acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity.
COMPLETED
NA
129 participants
Day 8 (-0/+3 days), each study lens type
2023-04-18
Participant Flow
Subjects were recruited from 8 investigative sites in the US.
Of the 129 enrolled, 3 subjects were screen failures prior to randomization. This reporting group includes all randomized subjects, as treated (126).
Unit of analysis: eyes
Participant milestones
| Measure |
PRECISION1, Then Biotrue
Verofilcon A contact lenses worn first, with nesofilcon A contact lenses worn second, as randomized. Each study lens type will be worn bilaterally (in both eyes) at least 10 hours per day for 8 -0/+3 days. A fresh pair of lenses was worn each day.
|
Biotrue, Then PRECISION1
Nesofilcon A contact lenses worn first, with verofilcon A contact lenses worn second, as randomized. Each study lens type will be worn bilaterally (in both eyes) at least 10 hours per day for 8 -0/+3 days. A fresh pair of lenses was worn each day.
|
|---|---|---|
|
First Wear Period, 8 -0/+3 Days
STARTED
|
62 124
|
64 128
|
|
First Wear Period, 8 -0/+3 Days
COMPLETED
|
62 124
|
64 128
|
|
First Wear Period, 8 -0/+3 Days
NOT COMPLETED
|
0 0
|
0 0
|
|
Second Wear Period, 8 -0/+3 Days
STARTED
|
62 124
|
64 128
|
|
Second Wear Period, 8 -0/+3 Days
COMPLETED
|
62 124
|
64 128
|
|
Second Wear Period, 8 -0/+3 Days
NOT COMPLETED
|
0 0
|
0 0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Clinical Performance of Two Daily Disposable Soft Contact Lenses
Baseline characteristics by cohort
| Measure |
PRECISION1, Then Biotrue
n=62 Participants
Verofilcon A contact lenses worn first, with nesofilcon A contact lenses worn second, as randomized. Each study lens type will be worn bilaterally (in both eyes) at least 10 hours per day for 8 -0/+3 days. A fresh pair of lenses was worn each day.
|
Biotrue, Then PRECISION1
n=64 Participants
Nesofilcon A contact lenses worn first, with verofilcon A contact lenses worn second, as randomized. Each study lens type will be worn bilaterally (in both eyes) at least 10 hours per day for 8 -0/+3 days. A fresh pair of lenses was worn each day.
|
Total
n=126 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
31.4 years
STANDARD_DEVIATION 8.2 • n=5 Participants
|
33.5 years
STANDARD_DEVIATION 7.3 • n=7 Participants
|
32.4 years
STANDARD_DEVIATION 7.8 • n=5 Participants
|
|
Sex: Female, Male
Female
|
42 Participants
n=5 Participants
|
42 Participants
n=7 Participants
|
84 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
20 Participants
n=5 Participants
|
22 Participants
n=7 Participants
|
42 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
9 Participants
n=5 Participants
|
6 Participants
n=7 Participants
|
15 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
52 Participants
n=5 Participants
|
58 Participants
n=7 Participants
|
110 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
White
|
57 Participants
n=5 Participants
|
61 Participants
n=7 Participants
|
118 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Black or African American
|
2 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Asian
|
0 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Other
|
2 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Multi-racial
|
0 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Missing data
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Day 8 (-0/+3 days), each study lens typePopulation: Full Analysis Set: All randomized subjects who were exposed to any study lenses evaluated in this clinical study with data at Day 8.
Visual Acuity (VA) was collected for each eye individually with study lenses in place using a letter chart. VA was measured in logarithm of the minimum angle of resolution (logMAR). A logMAR value of 0 corresponds to 20/20 Snellen acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity.
Outcome measures
| Measure |
PRECISION1
n=252 eyes
Verofilcon A contact lenses worn in Period 1 or Period 2, as randomized, in both eyes during waking hours only at least 10 hours per day for -0/+3 days. A fresh pair of lenses was worn each day.
|
Biotrue
n=252 eyes
Nesofilcon A contact lenses worn in Period 1 or Period 2, as randomized, in both eyes during waking hours only at least 10 hours per day for -0/+3 days. A fresh pair of lenses was worn each day.
|
|---|---|---|
|
Least Squares Mean Distance Visual Acuity (VA) With Study Lenses
|
-0.13 logMAR
Standard Error 0.006
|
-0.13 logMAR
Standard Error 0.006
|
Adverse Events
Pretreatment
PRECISION1 Ocular
PRECISION1 NonOcular
Biotrue Ocular
Biotrue NonOcular
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Clinical Project Lead, Vision Care
Alcon Research, LLC
Results disclosure agreements
- Principal investigator is a sponsor employee Sponsor reserves the right of prior review of any publication or presentation of information related to the study,
- Publication restrictions are in place
Restriction type: OTHER